A kind of polyimide fiber and its preparation method and use

The preparation of polyimide fibers with specific morphology and rough surfaces through wet spinning process solves the problems of complex preparation, high cost and poor antibacterial and antiviral effects in the prior art, and achieves efficient antibacterial and antiviral performance and environmentally friendly production process.

CN115748008BActive Publication Date: 2024-11-29NANJING ADVANCED ACAD OF LIFE & HEALTH +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111027069.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-09-02
Publication Date
2024-11-29
Estimated Expiration
2041-09-02

AI Technical Summary

Technical Problem

The existing polyimide fiber preparation methods are complex, costly, high environmental pressure, and difficult to achieve the intrinsic broad-spectrum antibacterial and antiviral effects.

Method used

Wet spinning process is used to prepare polyimide fibers with specific morphology and rough surfaces. The spinning holes are extruded in medium and high temperature pure water solidification bath through polyamic acid spinning raw liquid to form a skin core layer structure, combining sub-combination Amination treatment resulted in fibers with a roughness of 0.1-0.4 μm.

Benefits of technology

With the need for additional antibacterial agents, polyimide fiber has an antibacterial and antiviral inhibition rate of ≥90%, which is effective against a variety of bacteria and viruses, and is simple in process and environmentally friendly, reducing production costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003243944460000111
    Figure BDA0003243944460000111
  • Figure BDA0003243944460000112
    Figure BDA0003243944460000112
  • Figure BDA0003243944460000121
    Figure BDA0003243944460000121
Patent Text Reader

Abstract

The present invention relates to a polyimide fiber and a preparation method and use thereof. Specifically, the present invention provides a polyimide fiber having intrinsic broad-spectrum antibacterial and antiviral activity and being safe and harmless. The outer surface of the polyimide fiber of the present invention has a specific morphology and surface roughness, so that the polyimide fiber has excellent intrinsic broad-spectrum antibacterial and antiviral activity without modification and modification. The polyimide fiber of the present invention also has good biological safety. The present invention also provides a preparation method and use of the polyimide fiber suitable for large-scale production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a polyimide fiber and a preparation method and application thereof, and in particular to a polyimide fiber which has intrinsic broad-spectrum antibacterial and antiviral properties and is safe and harmless. Background Art

[0002] Polyimide fiber is a high-performance organic fiber. In addition to high and low temperature resistance, high strength, high modulus, high insulation, good impact resistance, chemical corrosion resistance and dimensional stability, polyimide fiber has a low density, is about 40% lighter than glass fiber, and is about 20% lighter than carbon fiber. It has good resistance to ultraviolet radiation, low water absorption and outstanding resistance to wet and hot aging, which can effectively avoid the problem of long-term performance degradation of aramid fiber products due to high water absorption and UV aging resistance. Composite materials prepared with polyimide fiber have very high specific strength and specific modulus, as well as excellent insulation, radiation resistance and low moisture absorption, as well as high and low temperature resistance that other organic fibers cannot match.

[0003] Due to its chemical structure and spinning process, the surface of polyimide fiber is inert, which leads to poor wettability between fiber and matrix resin, so it is particularly important to improve the surface roughness of fiber. Roughening the fiber surface can improve the wettability between fiber and resin matrix, thereby preventing the fiber from slipping in the resin matrix. In addition, studies have shown that a certain rough micro-nano structure on the surface of the material can inhibit the adhesion of bacteria or kill bacteria.

[0004] Common methods for roughening the surface of polyimide fibers mainly include chemical modification, plasma treatment, and alkaline hydrolysis. The above methods help to improve the interfacial bonding between the fiber and the resin matrix, but these methods are all implemented on the basis of existing fibers, which not only increases the complexity of the process, but also increases costs and environmental pressures to varying degrees.

[0005] In order to solve the shortcomings of the existing technology, the field urgently needs to find a preparation method of polyimide fiber with mild reaction conditions, safety, harmlessness, low cost, and green environmental protection, while giving it a rough surface to promote the wide application of polyimide fiber in intrinsic broad-spectrum antibacterial and antiviral aspects. Summary of the invention

[0006] The object of the present invention is to provide a safe and harmless weavable fiber material having intrinsic broad-spectrum antibacterial and antiviral activities.

[0007] In a first aspect of the present invention, there is provided a polyimide fiber with an intrinsic broad-spectrum antibacterial and antiviral property, wherein the polyimide fiber has a core-skin structure, wherein the core-skin structure is formed by wet spinning of a polyamic acid spinning solution, and the polyimide fiber has a rough outer surface derived from wet spinning, wherein the roughness Ra of the rough outer surface is 0.1-0.4 μm;

[0008] Furthermore, the polyimide fiber has antibacterial and antiviral activities in itself without any additional antibacterial and antiviral agents.

[0009] Wherein, the antibacterial activity includes antibacterial activity against the following bacteria or fungi: Escherichia coli, Candida albicans, and Staphylococcus aureus;

[0010] The antiviral activity includes antiviral activity against the following viruses: vesicular stomatitis virus (VSV), new coronavirus pseudovirus and influenza virus.

[0011] In another preferred embodiment, the roughness Ra of the rough outer surface is 0.12-0.3 μm.

[0012] In another preferred embodiment, the Staphylococcus aureus includes drug-resistant Staphylococcus aureus (such as MRSA or multi-drug resistant Staphylococcus aureus) and non-drug-resistant Staphylococcus aureus.

[0013] In another preferred embodiment, the Candida albicans includes drug-resistant Candida albicans and non-drug-resistant Candida albicans.

[0014] In another preferred embodiment, the antibacterial activity refers to an inhibition rate of ≥90% against bacteria or fungi, preferably ≥95%, and more preferably ≥99%.

[0015] In another preferred embodiment, the antiviral activity refers to an inhibition rate of ≥90% against viruses, preferably ≥95%, and more preferably ≥99%.

[0016] In another preferred embodiment, the antibacterial activity and antiviral activity are inhibition rates compared with a control group without adding the polyimide fiber (or a control group with adding cotton sheets).

[0017] In another preferred embodiment, the antibacterial activity and antiviral activity are measured using the corresponding national standards (such as GB / T 20944.2-2007, etc.) used in the examples.

[0018] In another preferred embodiment, the polyamic acid spinning solution contains:

[0019] (Z1) a diamine compound, wherein the diamine compound is selected from the group consisting of p-phenylenediamine, diaminodiphenyl ether, diaminodiphenylmethane, diaminobenzophenone, or a combination thereof; and

[0020] (Z2) a dianhydride compound, wherein the dianhydride compound is selected from the group consisting of pyromellitic dianhydride, biphenyltetracarboxylic dianhydride, biphenyl ether dianhydride, benzophenonetetracarboxylic dianhydride, or a combination thereof.

[0021] In another preferred embodiment, the polyimide fiber has one or more of the following properties:

[0022] (a) Denier 0.8~7dtex;

[0023] (b) breaking strength>4.0cN / dtex;

[0024] (c) elongation at break > 5.0%;

[0025] (d) Moisture regain (20℃×65%): 0.5%~2%;

[0026] (e) Dry heat shrinkage (280°C × 30min) < 0.6%;

[0027] (f) Limiting oxygen index ≥ 36%;

[0028] (g) Long-term use temperature ≤ 280℃.

[0029] In another preferred embodiment, the polyimide fiber is prepared by a method comprising the following steps (i.e., the method described in the second aspect):

[0030] (S1) providing a polyamic acid spinning solution, wherein the polyamic acid spinning solution comprises: a first solvent, a diamine compound and a dianhydride compound, wherein the diamine compound and the dianhydride compound form polyamic acid through a polymerization reaction in the first solvent;

[0031] (S2) extruding a polyamic acid spinning stock solution through a spinneret and coagulating it in a coagulation bath to form polyamic acid fibers, wherein the coagulation bath is an aqueous solvent, and the aqueous solvent does not contain an organic solvent or substantially does not contain an organic solvent;

[0032] (S3) The polyamic acid fiber is subjected to imidization treatment to form the polyimide fiber.

[0033] In a second aspect of the present invention, a method for preparing the polyimide fiber according to the first aspect of the present invention is provided, comprising the following steps:

[0034] (S1) providing a polyamic acid spinning solution, wherein the polyamic acid spinning solution comprises: a first solvent, a diamine compound and a dianhydride compound, wherein the diamine compound and the dianhydride compound form polyamic acid through a polymerization reaction in the first solvent;

[0035] (S2) extruding a polyamic acid spinning stock solution through a spinneret and coagulating it in a coagulation bath to form polyamic acid fibers, wherein the coagulation bath is an aqueous solvent, and the aqueous solvent does not contain an organic solvent or substantially does not contain an organic solvent;

[0036] (S3) imidizing the polyamic acid fiber to form the polyimide fiber. In another preferred embodiment, the content of the organic solvent in the coagulation bath is ≤1wt%, preferably ≤0.1wt%, and more preferably 0wt%, based on the total weight of the coagulation bath.

[0037] In another preferred embodiment, in step (S2), the solidification includes solidification in a solidification well.

[0038] In another preferred embodiment, the (Z-axis) depth of the coagulation well is 25-100 cm, preferably 30-80 cm, and more preferably 40-60 cm.

[0039] In another preferred embodiment, in step (S2), the polyamic acid spinning solution is extruded through the spinneret, enters the coagulation bath at a certain angle (preferably horizontally or nearly horizontally, or vertically or nearly vertically), and sinks (vertically or substantially vertically) and coagulates in the coagulation well under the action of gravity.

[0040] In another preferred embodiment, when the spinneret enters the coagulation bath at a certain angle (preferably horizontal or nearly horizontal), the length of the coagulation well (i.e. the length of the coagulation well in the X-axis direction or the horizontal advancing direction of the spinneret) is 10-60 cm, preferably 15-50 cm.

[0041] In another preferred embodiment, in step (S2), the polyamic acid spinning solution is extruded through the spinneret, enters the coagulation bath in a vertical or nearly vertical direction, and sinks and coagulates in the coagulation well under the action of gravity. In another preferred embodiment, the coagulation bath is composed of pure water.

[0042] In another preferred embodiment, the temperature of the coagulation bath is 40-60°C.

[0043] In another preferred embodiment, the temperature of the polyamic acid spinning solution is 0°C±5°C.

[0044] In another preferred embodiment, step (S2) further comprises degassing the polyamic acid spinning solution.

[0045] In another preferred embodiment, the degassing treatment is vacuum degassing.

[0046] In another preferred embodiment, the step (S1) comprises: adding a diamine compound to a first solvent, and after the diamine compound is completely dissolved, adding a dianhydride compound to the mixture, and stirring to carry out a polymerization reaction until the apparent viscosity of the reaction solution no longer changes, thereby obtaining a polyamic acid spinning solution.

[0047] In another preferred embodiment, in step (S1), the first solvent is selected from the following group: N,N-dimethylformamide, N-methylpyrrolidone, N,N-dimethylacetamide, or a combination thereof.

[0048] In another preferred embodiment, in step (S1), the diamine compound is selected from the following group: p-phenylenediamine, diaminodiphenyl ether, diaminodiphenylmethane, diaminobenzophenone, or a combination thereof.

[0049] In another preferred embodiment, in step (S1), the dianhydride compound is selected from the following group: pyromellitic dianhydride, biphenyltetracarboxylic dianhydride, biphenyl ether dianhydride, benzophenonetetracarboxylic dianhydride, or a combination thereof.

[0050] In another preferred embodiment, in step (S1), the molar ratio of the diamine compound to the dianhydride compound is (0.5-2):(0.5-2), preferably (0.8-1.2):(0.8-1.2), and more preferably (0.95-1.05):(0.95-1.05).

[0051] In another preferred embodiment, in step (S3), the imidization treatment includes thermal imidization, chemical imidization, or a combination thereof.

[0052] In another preferred embodiment, in step (S3), the imidization treatment is thermal imidization.

[0053] In another preferred embodiment, the temperature of the imidization treatment is ≤400°C.

[0054] In another preferred embodiment, the thermal imidization treatment includes thermal stretching.

[0055] In another preferred embodiment, the imidization treatment includes stretching the coagulated polyamic acid fibers.

[0056] In another preferred embodiment, the draft ratio of the coagulated polyamic acid fiber is 1 to 8 times.

[0057] In another preferred embodiment, the concentration of the polyamic acid spinning solution is 5 to 20 wt %.

[0058] In another preferred embodiment, in step (S1), during the process of adding the dianhydride compound, the temperature of the reaction solution is controlled at 0°C±5°C.

[0059] In a third aspect of the present invention, a fabric is provided, wherein the fabric contains the polyimide fiber according to the first aspect of the present invention.

[0060] In another preferred example, the fabric is polyimide fabric.

[0061] In another preferred example, the polyimide fabric is made of polyimide fibers, or mainly contains polyimide fibers.

[0062] In another preferred embodiment, the fabric contains ≥30wt%, preferably ≥50wt%, more preferably ≥70wt% or ≥90wt% of polyimide fibers.

[0063] In a fourth aspect of the present invention, there is provided a use of the polyimide fiber according to the first aspect of the present invention or the fabric according to the third aspect of the present invention for preparing an antimicrobial product.

[0064] In another preferred embodiment, the products include: daily products and medical products.

[0065] In another preferred embodiment, the products include: clothes and masks.

[0066] In another preferred embodiment, the microorganisms include bacteria, fungi, viruses, and mites.

[0067] In another preferred embodiment, the bacteria is selected from the following group: Escherichia coli (K12), Enterobacter cloacae, Klebsiella pneumoniae, Klebsiella pneumoniae subsp. pneumoniae, and Staphylococcus aureus.

[0068] In another preferred embodiment, the fungus is selected from the following group: Candida albicans SC5314, resistant Candida albicans, Candida glabrata, Candida krusei or Candida parapsilosis.

[0069] In another preferred embodiment, the fabric can be used to inhibit drug-resistant bacteria.

[0070] In another preferred embodiment, the drug-resistant bacteria are Staphylococcus aureus and clinically drug-resistant Candida albicans.

[0071] In another preferred example, the fungus includes mold.

[0072] In another preferred embodiment, the mold is selected from the following group: Aspergillus niger, Trichoderma viride, Penicillium funiculosum, and Chaetomium globosum.

[0073] In another preferred embodiment, the virus is selected from the following group: vesicular stomatitis virus (VSV), new coronavirus pseudovirus, influenza A virus (H3N2).

[0074] In another preferred embodiment, the fabric does not contain additional antimicrobial agents and / or preservatives.

[0075] In a fifth aspect of the present invention, a method for inhibiting pathogens in vitro is provided, comprising the steps of contacting the polyimide fiber or fabric thereof according to the first aspect of the present invention with pathogens, thereby inhibiting the pathogens.

[0076] In another preferred embodiment, the contact between the pathogen and the fiber is carried out under liquid conditions.

[0077] In another preferred embodiment, the polyimide fiber has good biocompatibility and is safe and harmless.

[0078] In another preferred embodiment, the method is non-therapeutic and non-diagnostic.

[0079] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here. BRIEF DESCRIPTION OF THE DRAWINGS

[0080] Figure 1 : Scanning electron microscope characterization of the polyimide fiber of the present invention.

[0081] Figure 2 : Experiment on the anti-vesicular stomatitis virus (VSV) of polyimide fiber.

[0082] Figure 3 : Experiment on anti-new coronavirus pseudovirus of polyimide fiber.

[0083] Figure 4 :The skin surface status of female and male rabbits after depilation without any stimulation 1h, 24h, and 72h later.

[0084] Figure 5 : The skin surface status of female and male rabbits after hair removal and stimulation with polyimide for 24 hours, and then after the irritant was removed for 1 hour, 24 hours, and 72 hours.

[0085] Figure 6 : The skin surface status of female and male rabbits after hair removal and stimulation with 2,4-dinitrochlorobenzene for 24 hours, and then after the irritant was removed for 1 hour, 24 hours, and 72 hours.

[0086] Figure 7 :The skin surface status of female and male rabbits after hair removal and stimulation with cotton for 24 hours, and 1 hour, 24 hours, and 72 hours after the irritant was removed.

[0087] Figure 8:Single irritation test on intact skin. The skin surface status of depilated female and male rabbits was observed after 24 hours of stimulation with 2,4-dinitrochlorobenzene, cotton, polyimide and blank treatment. The skin surface status of the rabbits was observed after 1 hour, 24 hours and 72 hours of removal of the irritants.

[0088] Fig. 9 : Intact skin multiple stimulation test, after multiple stimulation of depilated female and male rabbits with 2,4-dinitrochlorobenzene, cotton, polyimide and blank treatment, the state of the rabbit skin surface was observed 1h, 24h and 72h after the irritants were removed.

[0089] Fig.10 : Single irritation test on damaged skin. Female and male rabbits with hair removal and damaged skin were stimulated with 2,4-dinitrochlorobenzene, cotton, polyimide and blank treatment for 24 hours. The state of the rabbit skin surface was observed 1 hour, 24 hours and 72 hours after the irritants were removed. DETAILED DESCRIPTION

[0090] The present invention has been extensively and deeply studied, and after a large number of screenings, a novel wet spinning process has been developed for the first time, and a polyimide fiber with a rough surface and a specific morphology has been developed. The preparation process of the present invention is simple and the reaction conditions are mild. The polyimide fiber of the present invention has excellent antibacterial and antiviral properties and mechanical properties, and can be used to prepare a polyimide fabric with excellent antimicrobial properties. On this basis, the present invention is completed.

[0091] Polyimide fiber

[0092] As used herein, the terms "polyimide fiber of the present invention", "fiber of the present invention" or "intrinsic broad-spectrum antibacterial and antiviral polyimide fiber of the present invention" are used interchangeably to refer to the polyimide fiber described in the first aspect of the present invention. It should be understood that the term includes various different fibers whose main components or main components are the polyimide fiber described in the first aspect of the present invention. In addition, the term may also include unmodified or modified polyimide fibers.

[0093] The polyimide fiber of the present invention has a specific morphology and a specific surface roughness, and the polyimide fiber of the present invention itself has excellent antibacterial and antiviral properties and mechanical properties. Under an electron microscope, the polyimide fiber with a rough surface of the present invention has different tiny rough structures such as grooves, depressions, protrusions, and micro-scales on the surface. The specific embodiments of the present invention show that the polyimide fiber of the present invention has excellent resistance to pathogenic microorganisms (such as bacteria, fungi, and viruses).

[0094] Typically, the polyimide fiber of the present invention has a skin-core structure, and the polyimide fiber has a rough outer surface. The present invention's research shows that this specific skin-core structure and specific morphology and roughness are crucial to giving the polyimide fiber of the present invention excellent antibacterial / antiviral properties.

[0095] In the present invention, the roughness Ra of the rough outer surface of the polyimide fiber is generally 0.1-0.4 μm, preferably 0.12-0.3 μm.

[0096] Experiments show that the polyimide fiber of the present invention has antibacterial and antiviral activities in the absence of additional antibacterial and antiviral agents. In addition, the polyimide fiber of the present invention also has certain anti-mite performance.

[0097] Experiments show that the antibacterial activity of the polyimide fiber of the present invention includes antibacterial activity against different bacteria such as bacteria and fungi, especially some clinical pathogens (including pathogens resistant to antibiotics, such as MRSA). Representative examples include (but are not limited to): Escherichia coli, Candida albicans, and Staphylococcus aureus.

[0098] In addition, the antiviral activity of the polyimide fiber of the present invention includes antiviral activity against DNA viruses, RNA viruses, and DNA / RNA viruses, especially some clinically pathogenic viruses. Representative examples include (but are not limited to): vesicular stomatitis virus (VSV), new coronavirus pseudovirus, influenza virus, parainfluenza virus, and enterovirus.

[0099] In the present invention, one pathogen that can be inhibited by the polyimide fiber of the present invention is Staphylococcus aureus, including drug-resistant Staphylococcus aureus (such as MRSA or multi-drug resistant Staphylococcus aureus) and non-drug-resistant Staphylococcus aureus.

[0100] In the present invention, one pathogen that can be inhibited by the polyimide fiber of the present invention is Candida albicans, including drug-resistant Candida albicans and non-drug-resistant Candida albicans.

[0101] In another preferred embodiment, the antibacterial activity refers to an inhibition rate of ≥90% against bacteria or fungi, preferably ≥95%, and more preferably ≥99%.

[0102] In another preferred embodiment, the antiviral activity refers to an inhibition rate of ≥90% against viruses, preferably ≥95%, and more preferably ≥99%.

[0103] In another preferred embodiment, the antibacterial activity and antiviral activity are inhibition rates compared with a control group without adding the polyimide fiber (or a control group with adding cotton sheets).

[0104] In another preferred embodiment, the antibacterial activity and antiviral activity are measured using the corresponding national standards (such as GB / T 20944.2-2007, etc.) used in the examples.

[0105] Preferably, the polyimide fiber of the present invention has one or more or all of the following properties:

[0106] (a) Denier 0.8~7dtex;

[0107] (b) breaking strength>4.0cN / dtex;

[0108] (c) elongation at break > 5.0%;

[0109] (d) Moisture regain (20℃×65%): 0.5%~2%;

[0110] (e) Dry heat shrinkage (280°C × 30min) < 0.6%;

[0111] (f) Limiting oxygen index ≥ 36%;

[0112] (g) Long-term use temperature ≤ 280℃.

[0113] Although the polyimide fiber of the present invention itself has intrinsic broad-spectrum antibacterial and antiviral activity, in order to further enhance the antibacterial or antiviral activity or impart other properties, additional antibacterial or antiviral agents, such as nanosilver (although it is usually not necessary to add), or additional functional layers (such as coating a waterproof layer on the outside) may be added or coated on the fiber of the present invention or its fabric.

[0114] Preparation of polyimide fiber of the present invention by wet spinning process

[0115] In the wet spinning process of the present invention, a specific large well depth and a medium-high temperature pure water coagulation bath are utilized to effectively control the fiber surface morphology, thereby preparing polyimide fibers with a rough outer surface having a specific morphology.

[0116] As used herein, the term "coagulation well" is a region defined in a coagulation bath and shaped like a trap, in which the spinnerets ejected through the spinneret holes sink due to the action of gravity and coagulate at the same time.

[0117] In the present invention, the polyamic acid spinning stock solution is extruded through the spinneret hole, and the formed spinnerets enter the coagulation bath at a certain angle, and sink (vertically or substantially vertically) and coagulate in the coagulation well under the action of gravity.

[0118] In a preferred embodiment, the spinneret enters the coagulation bath in a horizontal or nearly horizontal manner, and then enters the coagulation well, so as to be rapidly coagulated in the process of nearly vertical sinking.

[0119] In another preferred embodiment, the spinneret enters the coagulation bath vertically or substantially vertically, that is, directly enters the coagulation well, so that the spinneret is rapidly coagulated during the vertical or nearly vertical sinking process. This method is conducive to sinking polyamic acid fibers with higher roughness and corresponding polyimide fibers.

[0120] In the present invention, by performing sinking-type rapid solidification in a specific solidification well, not only a rough surface with a specific morphology can be formed, but also the external force on the fiber cross section direction is made very uniform, so that the cross-sectional shape of the fiber can remain uniform during the molding process.

[0121] In the present invention, under specific well depth conditions, in the coagulation well, the flow direction of the fiber bundle is basically consistent with its gravity direction, which makes the external force exerted on the spinneret in the direction of the fiber cross section uniform, so that the cross-sectional shape of the fiber can remain uniform during the forming process.

[0122] In the present invention, a medium-high temperature pure water coagulation bath is used. Since the concentration difference between pure water and spinning solution is large, and the high temperature accelerates the molecular diffusion movement, the solvent in the spinning solution can be quickly diffused into the water. The coagulation speed of the primary fiber is fast, and a skin-core structure will be formed in a short time. The pressure difference between the inside and outside of the fiber is large, the surface defects are many, and the roughness is large. This structure will be retained in the fiber. After heat treatment (or imidization treatment), it will eventually become a polyimide fiber with uniform thickness but large surface roughness.

[0123] In the method of the present invention, a representative polyamic acid spinning solution for preparing the polyimide fiber of the present invention may contain:

[0124] (Z1) a diamine compound, wherein the diamine compound is selected from the group consisting of p-phenylenediamine, diaminodiphenyl ether, diaminodiphenylmethane, diaminobenzophenone, or a combination thereof; and

[0125] (Z2) a dianhydride compound, wherein the dianhydride compound is selected from the group consisting of pyromellitic dianhydride, biphenyltetracarboxylic dianhydride, biphenyl ether dianhydride, benzophenonetetracarboxylic dianhydride, or a combination thereof.

[0126] application

[0127] The present invention also provides various applications of the polyimide fiber of the present invention.

[0128] The polyimide fiber of the present invention can be made into different fabrics, such as daily necessities and medical products. The products of the present invention are suitable for various occasions requiring antibacterial / antiviral properties.

[0129] Typically, the fabric of the present invention contains the polyimide fiber of the present invention, or is substantially composed of the polyimide fiber of the present invention. Generally, the fabric of the present invention can be made by braiding, weaving, and other different methods.

[0130] The polyimide fiber or fabric thereof of the present invention can be used to prepare antimicrobial products.

[0131] The present invention also provides a method for inhibiting pathogens, comprising the steps of contacting the polyimide fiber or fabric of the present invention with pathogens, thereby inhibiting pathogens (including bacteria, fungi, viruses, etc.). The method can be therapeutic or non-therapeutic. The preferred method for inhibiting pathogens is an in vitro non-therapeutic method.

[0132] The main advantages of the present invention include:

[0133] (1) The wet spinning technology of the polyimide fiber described in the present invention avoids adding organic solvents into the coagulation bath, which is green and environmentally friendly.

[0134] (2) The polyimide fiber surface described in the present invention does not need to be subjected to secondary modification, such as plasma etching or alkaline solution hydrolysis, to obtain a specific rough surface structure with excellent antibacterial properties, thereby avoiding damage to the mechanical properties of the fiber caused by secondary modification.

[0135] (3) The solvent used in the preparation process of the polyimide fiber described in the present invention is mainly water.

[0136] (4) The preparation process of the present invention is simple, no secondary modification is required, the post-processing process is simplified, and it is conducive to industrial production.

[0137] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are calculated by weight.

[0138] The ordinary polyimide fiber used as a control in the examples is a commercially available polyimide fiber.

[0139] Example 1: Preparation of polyimide fibers

[0140] The steps of preparing polyimide fiber by wet process are as follows:

[0141] (1) Preparation of polyamide acid spinning solution

[0142] Weigh diaminodiphenyl ether and pyromellitic anhydride at a molar mass ratio of 1:1. After diaminodiphenyl ether is completely dissolved in N,N-dimethylformamide, add pyromellitic anhydride. During the feeding process, control the reaction temperature to 0℃±5℃, and stir until the apparent viscosity of the solution remains unchanged to obtain polyamic acid spinning solution. Take a certain mass of the above polyamic acid spinning solution, place it in a 100℃ oven and dry it until the mass remains unchanged. The solid matter obtained by weighing is the net weight of the polyamic acid. According to the calculation formula: concentration = net weight of polyamic acid / mass of polyamic acid spinning solution, the concentration is 15wt%.

[0143] (2) Spinning of polyamic acid spinning solution

[0144] The polyamic acid spinning stock solution is filtered and vacuum degassed, and then extruded through a spinneret in a horizontal direction; the extrudate is put into a coagulation bath for coagulation to obtain polyamic acid fibers. The coagulation bath has a depth of 50 cm, and the coagulation bath is pure water at a temperature of 50°C.

[0145] (3) Imidization treatment of polyamic acid fibers

[0146] The polyamic acid fiber is subjected to heat drawing with a drawing ratio of 6 times and a temperature of 350° C. for 2 hours to obtain a polyimide fiber.

[0147] The obtained polyimide fibers were characterized by scanning electron microscopy (magnification 10,000 times).

[0148] The results are as follows Figure 1 As shown, the polyimide fiber prepared by the present invention has a cylindrical shape with uniform size as a whole, and the surface has different micro rough structures such as grooves, depressions, protrusions, and micro-scales. After AFM testing, the roughness calculation formula is selected:

[0149]

[0150] The roughness of the obtained polyimide fiber was Ra=0.24 μm.

[0151] Example 2: Preparation of polyimide fibers

[0152] The polyimide fiber is prepared by wet method, and the specific steps are as follows;

[0153] (1) Preparation of polyamide acid spinning solution

[0154] Weigh p-phenylenediamine and pyromellitic anhydride at a molar mass ratio of 1:1.05. After p-phenylenediamine is completely dissolved in N-methylpyrrolidone, add pyromellitic anhydride. During the feeding process, control the reaction temperature to 0℃±5℃, and stir until the apparent viscosity of the solution remains unchanged to obtain a polyamic acid spinning solution. Take a certain mass of the above polyamic acid spinning solution, place it in a 100℃ oven and dry it until the mass remains unchanged. The solid matter obtained by weighing is the net weight of the polyamic acid. According to the calculation formula: concentration = net weight of polyamic acid / mass of polyamic acid spinning solution, the concentration is 10wt%.

[0155] (2) Spinning of polyamic acid spinning solution

[0156] The polyamic acid spinning stock solution is filtered and vacuum degassed, and then extruded through a spinneret in a vertical direction; the extrudate is put into a coagulation bath for coagulation to obtain polyamic acid fibers. The coagulation bath has a depth of 40 cm, and the coagulation bath is pure water at a temperature of 40°C.

[0157] (3) Imidization treatment of polyamic acid fibers

[0158] The polyamic acid fiber is subjected to heat drawing at a drawing ratio of 1 and a temperature of 400° C. for 2 hours to obtain a polyimide fiber.

[0159] After AFM testing, the roughness calculation formula was selected:

[0160]

[0161] The roughness of the obtained polyimide fiber was Ra=0.30 μm.

[0162] Example 3: Preparation of polyimide fibers

[0163] The polyimide fiber is prepared by wet method, and the specific steps are as follows;

[0164] (1) Preparation of polyamide acid spinning solution

[0165] Weigh p-phenylenediamine and biphenyltetracarboxylic anhydride at a molar mass ratio of 1.05:1. After p-phenylenediamine is completely dissolved in N,N-dimethylacetamide, add biphenyltetracarboxylic anhydride. During the feeding process, control the reaction temperature to 0℃±5℃, and stir until the apparent viscosity of the solution remains unchanged to obtain the polyamic acid spinning solution. Take a certain mass of the above polyamic acid spinning solution, place it in a 100℃ oven and dry it until the mass remains unchanged. The solid matter obtained by weighing is the net weight of the polyamic acid. According to the calculation formula: concentration = net weight of polyamic acid / mass of polyamic acid spinning solution, the concentration is 5wt%.

[0166] (2) Spinning of polyamic acid spinning solution

[0167] The polyamic acid spinning stock solution is filtered and vacuum degassed, and then extruded through a spinneret at a 45° downward angle; the extrudate is put into a coagulation bath for coagulation to obtain polyamic acid fibers. The coagulation bath has a depth of 60 cm, and the coagulation bath is pure water at a temperature of 60°C.

[0168] (3) Imidization treatment of polyamic acid fibers

[0169] The polyamic acid fiber is subjected to heat drawing with a drawing ratio of 5 times and a temperature of 320° C. for 2 hours to obtain a polyimide fiber.

[0170] After AFM testing, the roughness calculation formula was selected:

[0171]

[0172] The roughness of the polyimide fiber was Ra=0.15 μm.

[0173] Example 4: Preparation of polyimide fibers

[0174] The polyimide fiber is prepared by wet method, and the specific steps are as follows;

[0175] (1) Preparation of polyamide acid spinning solution

[0176] Weigh p-phenylenediamine and biphenyltetracarboxylic anhydride at a molar mass ratio of 0.95:1. After p-phenylenediamine is completely dissolved in N,N-dimethylacetamide, add biphenyltetracarboxylic anhydride. During the feeding process, control the reaction temperature to 0℃±5℃, and stir until the apparent viscosity of the solution remains unchanged to obtain the polyamic acid spinning solution. Take a certain mass of the above polyamic acid spinning solution, place it in a 100℃ oven and dry it until the mass remains unchanged. The solid matter obtained by weighing is the net weight of the polyamic acid. According to the calculation formula: concentration = net weight of polyamic acid / mass of polyamic acid spinning solution, the concentration is 5wt%.

[0177] (2) Spinning of polyamic acid spinning solution

[0178] The polyamic acid spinning stock solution is filtered and vacuum degassed, and then extruded through a spinneret at a 60° downward angle; the extrudate is put into a coagulation bath for coagulation to obtain polyamic acid fibers. The coagulation bath has a depth of 60 cm, and the coagulation bath is pure water at a temperature of 60°C.

[0179] (3) Imidization treatment of polyamic acid fibers

[0180] The polyamic acid fiber is subjected to heat drawing with a drawing ratio of 4 times and a temperature of 320° C. for 2 hours to obtain a polyimide fiber.

[0181] After AFM testing, the roughness calculation formula was selected:

[0182]

[0183] The roughness of the obtained polyimide fiber was Ra=0.12 μm.

[0184] Example 5: Preparation of polyimide fibers

[0185] The polyimide fiber is prepared by wet method, and the specific steps are as follows;

[0186] (1) Preparation of polyamide acid spinning solution

[0187] Weigh diaminodiphenylmethane and benzophenone tetracarboxylic dianhydride at a molar mass ratio of 1.05:0.95. After diaminodiphenylmethane is completely dissolved in N,N-dimethylacetamide, add benzophenone tetracarboxylic dianhydride. During the feeding process, control the reaction temperature to 0℃±5℃, and stir until the apparent viscosity of the solution remains unchanged to obtain polyamic acid spinning solution. Take a certain mass of the above polyamic acid spinning solution, place it in a 100℃ oven and dry it until the mass remains unchanged. The solid matter obtained by weighing is the net weight of the polyamic acid. According to the calculation formula: concentration = net weight of polyamic acid / mass of polyamic acid spinning solution, the concentration is 20wt%.

[0188] (2) Spinning of polyamic acid spinning solution

[0189] The polyamic acid spinning stock solution is filtered and vacuum degassed, and then extruded through a spinneret in a horizontal direction; the extrudate is put into a coagulation bath for coagulation to obtain polyamic acid fibers. The coagulation bath has a depth of 55 cm, and the coagulation bath is pure water at a temperature of 45°C.

[0190] (3) Imidization treatment of polyamic acid fibers

[0191] The polyamic acid fiber is subjected to heat drawing with a drawing ratio of 8 times and a temperature of 370° C. for 2 hours to obtain a polyimide fiber.

[0192] After AFM testing, the roughness calculation formula was selected:

[0193]

[0194] The roughness of the obtained polyimide fiber was Ra=0.3 μm.

[0195] Example 6: Preparation of polyimide fibers

[0196] The polyimide fiber is prepared by wet method, and the specific steps are as follows;

[0197] (1) Preparation of polyamic acid spinning solution

[0198] Weigh diamine and dianhydride at a molar mass ratio of 1:1, wherein the diamine is a mixture of diaminodiphenylmethane and p-phenylenediamine at a molar mass ratio of 1:1, and the dianhydride is a mixture of benzophenonetetracarboxylic dianhydride and pyromellitic anhydride at a molar mass ratio of 1:1. After the diamine is completely dissolved in the solvent, the solvent is a mixture of N,N-dimethylacetamide and N-methylpyrrolidone at a volume ratio of 1:1. Then add dianhydride, control the reaction temperature to 0℃±5℃ during the feeding process, and stir until the apparent viscosity of the solution remains unchanged to obtain a polyamic acid spinning solution. Take a certain mass of the above-mentioned polyamic acid spinning solution, place it in a 100℃ oven and dry it until the mass remains unchanged, and weigh the solid matter obtained, which is the net weight of the polyamic acid. According to the calculation formula: concentration = net weight of polyamic acid / mass of polyamic acid spinning solution, the concentration is 20wt%.

[0199] (2) Spinning of polyamic acid spinning solution

[0200] The polyamic acid spinning stock solution is filtered and vacuum degassed, and then extruded through a spinneret in a horizontal direction; the extrudate is put into a coagulation bath for coagulation to obtain polyamic acid fibers. The coagulation bath has a depth of 50 cm, and the coagulation bath is pure water at a temperature of 45°C.

[0201] (3) Imidization treatment of polyamic acid fibers

[0202] The polyamic acid fiber is subjected to heat drawing with a drawing ratio of 7 times and a temperature of 350° C. for 2 hours to obtain a polyimide fiber.

[0203] After AFM testing, the roughness calculation formula was selected:

[0204]

[0205] The roughness of the obtained polyimide fiber was Ra=0.2 μm.

[0206] Example 7: Mildew resistance test

[0207] The polyimide fibers prepared in Examples 1-6 were used to make polyimide fabrics. Representative samples were selected from the polyimide fabrics and cut into circles or squares with a diameter or side length of 3.8±0.5 cm, a total of 6 pieces, and sterilized with high-pressure steam (121°C, 103 kPa) for 15 minutes. Then, the anti-mildew performance of the textiles was tested and evaluated in accordance with the National Standard of the People's Republic of China GB / T 24346-2009.

[0208] The antifungal properties of Aspergillus niger (ATCC16404), Trichoderma viride (CGMCC 3.2941), Penicillium funiculosum (CGMCC 3.3875) and Chaetomium globosum (CGMCC 3.3601) were evaluated.

[0209] The test rating criteria are as follows:

[0210] Level 0: No obvious mold growth under a magnifying glass;

[0211] Level 1: Mold growth is sparse or localized, covering less than 10% of the sample surface area;

[0212] Level 2: The mold covers 30% (10% to 30%) of the sample surface;

[0213] Level 3: The coverage area of ​​mold on the sample surface is 60% (30% to 60%);

[0214] Level 4: The mold coverage area on the sample surface reaches or exceeds 60%.

[0215] The results showed that the mildew resistance rating for the various mildews tested was 0, and no obvious mildew growth was observed under a magnifying glass, indicating that polyimide had a good mildew resistance effect on the various mildews.

[0216] Example 8: Antibacterial performance test (absorption method)

[0217] 0.2 mL of 1×10 5 ~3×10 5 The bacterial solution with a concentration of cfu / mL was dispersed and inoculated on a sterilized 0.40g±0.05g fabric sample, and after static culture for 18-24h, 20mL SCDLP medium was added, and the cells were shaken for 30s (swing amplitude of about 30cm), the cells were washed off, and samples were taken for counting. The antibacterial properties of textiles were tested and evaluated according to the national standard of the People's Republic of China GB / T 20944.2-2007 (absorption method).

[0218] In this example, the antibacterial properties of the polyimide fabric before cleaning against Escherichia coli (ATCC 8099), Staphylococcus aureus (ATCC 6538) and Candida albicans (ATCC 10231) were tested, as well as the resistance of the polyimide fabric to the above two bacteria and one fungus after cleaning 50 times.

[0219] For the fabric of the polyimide fiber prepared by Example 1, the test results are shown in Table 1:

[0220] Table 1 Antibacterial properties of polyimide fibers tested by absorption method

[0221]

[0222] The results showed that the inhibition rate of polyimide fabric against the above three common test bacteria was over 99%, both before and after washing 50 times.

[0223] The above results show that the antibacterial rate of the polyimide fabric of the present invention is greater than 99%, and thus has excellent antibacterial effect.

[0224] The fabrics made of polyimide fibers prepared in Examples 2-6 were tested in the same manner as above, and the antibacterial rates thereof were all greater than 99%.

[0225] Example 9: Antibacterial performance test (oscillation method)

[0226] Place 0.75 g ± 0.05 g of a 0.5 cm × 0.5 cm fabric sample in a 250 mL conical flask, sterilize with high temperature and high pressure, then add 70 mL of PBS and 5 mL of 2.5 × 10 5 ~3×10 5 The bacterial solution with a concentration of cfu / mL was cultured with shaking at 150rpm, and samples were taken and counted after 18 hours. The antibacterial properties of textiles were tested and evaluated according to the national standard of the People's Republic of China GB / T 20944.3-2008 (oscillation method).

[0227] In this example, the antibacterial properties of the polyimide fabric before washing against Escherichia coli (ATCC 8099), Staphylococcus aureus (ATCC 6538) and Candida albicans (ATCC 10231) were tested, as well as the resistance of the polyimide fabric to the above three bacteria after washing 50 times.

[0228] For the fabric of polyimide fiber prepared by Example 1, the test results are shown in Table 2:

[0229] Table 2 Oscillation method to test the antibacterial properties of polyimide fibers

[0230]

[0231] The results show that the inhibition rate of polyimide fabric against Escherichia coli and Staphylococcus aureus is more than 99% before and after washing for 50 times. The evaluation standard stipulates that an inhibition rate of bacteria ≥70% indicates that the fabric has an antibacterial effect; at the same time, the inhibition rate of polyimide fabric against Candida albicans before washing reached 92%, and the inhibition rate of the fungus after washing for 50 times was 98%. The evaluation standard stipulates that an inhibition rate of fungi ≥60% indicates an antibacterial effect.

[0232] The above results show that the polyimide fabric of the present invention has good inhibitory effects on bacteria and fungi.

[0233] After obtaining the resistance results of polyimide fabrics to the above three common test strains, the broad-spectrum antibacterial properties of polyimide fibers were studied. The standard is still the oscillation method to evaluate the antibacterial properties of textiles. So far, the antibacterial properties of polyimide fabrics against Escherichia coli (K12), Enterobacter cloacae, Klebsiella pneumoniae, Klebsiella pneumoniae subspecies pneumoniae, Staphylococcus aureus (super-resistant bacteria), Candida albicans SC53145, clinically resistant Candida albicans, Candida glabrata, Candida krusei and Candida parapsilosis with different genetic backgrounds have been tested (see Table 3 below for details).

[0234] The results showed that the resistance of polyimide fabric to all tested bacteria reached more than 88%. According to the description of the antibacterial properties of fabrics by the oscillation method, polyimide has good broad-spectrum antibacterial properties and can effectively inhibit the growth of most common clinical pathogenic microorganisms.

[0235] Table 3 Broad-spectrum antibacterial properties of polyimide fibers tested by oscillation method

[0236]

[0237] Example 10: Mite repellency test

[0238] According to the national standard of the People's Republic of China GB / T 24253-2009, the anti-mite performance of textiles was tested and evaluated. This example tests the repellency rate of polyimide fabrics for mites. The repellency rate and anti-mite effect are described as follows:

[0239] The avoidance rate is ≥95%, and the sample has a strong anti-mite effect;

[0240] The avoidance rate is ≥80%, and the sample has a strong anti-mite effect;

[0241] The avoidance rate is ≥60%, and the sample has an anti-mite effect.

[0242] For the fabric made of polyimide fiber prepared in Example 1, the results show that the anti-mite repellency rate of polyimide is 56%, close to 60%, indicating that the sample has a weak anti-mite effect. After subsequent processing and improvement, it may be closer to or reach a repellency rate of 60%.

[0243] Example 11: Antiviral performance test

[0244] Example 11.1: Anti-vesicular stomatitis virus (VSV) test

[0245] According to ISO18184:2019 testing standard, the shredded standard cotton fabric and polyimide fabric were mixed with 1×10 7pfu VSV-GFP / 25mL DMEM were mixed and shaken in a 50mL centrifuge tube. Vero cells were infected at MOI=0.01 after 0.5h, 1h, 2h and 4h, and observation and recording were performed at 12h and 24h.

[0246] Anti-VSV test results Figure 2 As shown, the resistance of the fabric made of polyimide fiber prepared in Example 1 to VSV increases with the increase of contact time. After the polyimide fabric was in contact with VSV for 4 hours, the green fluorescence of VSV completely disappeared, indicating that the virus was inactivated, that is, the antiviral activity rate of the polyimide fabric was as high as 100%. And the cell growth condition in the corresponding white field field was good, indicating that the disappearance of green fluorescence was indeed caused by the inactivation of the virus.

[0247] Example 11.2: Anti-COVID-19 Pseudovirus Test

[0248] The new coronavirus pseudovirus used in this embodiment can encode the new coronavirus spike glycoprotein (Spike, S protein), which is the key target for the new coronavirus to attach to and infect human cells; at the same time, the virus contains a firefly luciferase marker, and the new coronavirus pseudovirus content can be quantitatively calculated by testing the luminescence.

[0249] According to the ISO18184:2019 test standard, 0.2g, 0.4g, 0.8g and 1.6g of polyimide fabric (the fabric of polyimide fiber prepared in Example 1) were incubated with an equal amount of virus for 4 hours, and the antiviral rates were 53.7%, 67.6%, 69.2% and 85%, respectively. The experimental test results are as follows Figure 3 As shown, as the mass of polyimide fabric increases, its antiviral rate gradually increases, indicating that polyimide fabric has a significant inhibitory effect on the new coronavirus pseudovirus.

[0250] The results of the Luciferase quantitative test are shown in Table 4:

[0251] Table 4 Luciferase quantitative test

[0252]

[0253]

[0254] Example 11.3: Anti-influenza A virus (H3N2) test

[0255] According to the ISO18184:2019 testing standard, the antiviral activity of textiles was tested. The test was commissioned to the Guangdong Microbiological Analysis and Testing Center, and the test results are shown in Table 5.

[0256] After the polyimide fiber fabric prepared in Example 1 was in contact with influenza A virus (H3N2) for 2 hours, the inhibition rate of influenza A virus (H3N2) reached more than 50%, and after contacting for 4 hours, the inhibition rate of influenza A virus (H3N2) was as high as 90%, indicating that the polyimide fabric has excellent anti-influenza A virus (H3N2) activity.

[0257] Table 5 Anti-influenza A virus (H3N2) performance of polyimide fabrics

[0258]

[0259]

[0260] Example 12: MTT assay to detect cell activity

[0261] Take out the frozen Caco-2, Hela and Huvec epithelial cells from the liquid nitrogen container, treat them, resuspend them in DMEM culture medium containing 10% fetal bovine serum, and count them. Adjust the cell density to 1x10 3 / mL, inoculated into a 96-well cell culture plate. After overnight culture, add 100μL of polyimide fiber fabric extract (immerse the polyimide fiber fabric in the cell culture solution and extract at 37℃ for 24h to obtain the extract. The ratio of the weight of the polyimide fiber fabric material to the culture solution is 0.1g / ml.), and culture in a 37℃ cell culture incubator for 24h. Add 10μL of 0.5% MTT solution and continue to culture for 4h. Terminate the culture, remove the supernatant, add 150μL DMSO to the crystals at the bottom of the cell plate, and shake at a low speed on a shaker for 10min to fully dissolve the crystals; measure the absorbance at OD 490nm in an enzyme-linked immunosorbent assay and calculate the relative proliferation rate.

[0262] The scoring criteria for relative cell proliferation rate are shown in Table 6 below:

[0263] Table 6 Scoring criteria for relative cell proliferation rate

[0264]

[0265] For the fabric made of polyimide fiber prepared in Example 1, the test results (Table 7, Table 8, Table 9) show that the toxicity rating of the polyimide fabric to Huvec cells is 1, and the rating to Caco-2 and Hela cells is 2. Most cells have good morphology under the microscope, and there is no obvious cell rupture. Therefore, the safety of the polyimide fabric for cells is evaluated as qualified.

[0266] Table 7 Relative proliferation rate (RGR) (%) of Caco-2 cells by MTT method and toxicity rating of test materials

[0267]

[0268]

[0269] Table 8 Relative proliferation rate (RGR) (%) of Hela cells by MTT method and toxicity rating of test materials

[0270] Test Materials RGR Toxicity level Polyimide fabric 61.67 2 Positive Control 4.31 4 Blank control 100 0

[0271] Table 9 Relative proliferation rate RGR (%) of Huvec cells by MTT method and toxicity rating of test materials

[0272] Test Materials RGR Toxicity level Polyimide fabric 84.55 1 Positive Control 7.31 4 Blank control 100 0

[0273] Example 13: CCK-8 method for detecting cell proliferation and toxicity

[0274] Similar to the MTT method, Caco-2, Hela and Huvec epithelial cells were cultured at 1x10 3 cfu / mL were inoculated into 96-well cell culture plates. After overnight culture, 100 μL of polyimide fiber fabric extract was added and cultured in a 37°C cell culture incubator for 24 h. 10 μL of CCK solution was added to each well and cultured in an incubator for 1-4 h. The absorbance at 450 nm was measured by an ELISA reader and the relative proliferation rate was calculated.

[0275] According to the scoring criteria of the relative proliferation rate of cells in Table 6, the toxicity of the fabric of the polyimide fiber prepared in Example 1 to Caco-2 cells was rated as Grade 0 (Table 10), and to Hela (Table 11) and Huvec cells (Table 12) was rated as Grade 1. Therefore, the test results of the CCK-8 method show that polyimide is safe and non-toxic.

[0276] Table 10 Relative proliferation rate (RGR) (%) of Caco-2 cells detected by CCK method and toxicity rating of test materials

[0277] Test Materials RGR Toxicity level Polyimide fabric 107.48 0 Positive Control 20.08 4 Blank control 100 0

[0278] Table 11 Relative proliferation rate RGR (%) of Hela cells detected by CCK method and toxicity rating of test materials

[0279]

[0280]

[0281] Table 12 Relative proliferation rate RGR (%) of Huvec cells detected by CCK method and toxicity rating of test materials

[0282] Test Materials RGR Toxicity level Polyimide fabric 85.11 1 Positive Control 4.43 4 Blank control 100 0

[0283] Example 14: Blood compatibility test - hemolysis test

[0284] According to 1cm 2 :10mL ratio (polyimide fabric area to saline weight volume ratio) to prepare test sample A, negative control B is 10mL saline, and positive control C is 10mL distilled water. Add 0.4mL potassium oxalate reagent (20g / L) to 8mL fresh rabbit blood, and then add 10mL saline to obtain fresh diluted rabbit anticoagulated blood. Put A, B, and C test tubes (two parallel experimental samples in each group) into a 37℃ water bath for 30min, then add 0.2mL of prepared fresh rabbit anticoagulated blood to each test tube, shake slowly to mix, and put the test tube into a 37℃ water bath again for 1h. Pour the liquid in each test tube into a centrifuge tube, centrifuge at 800rpm for 5 minutes, take the supernatant and measure the absorbance at a wavelength of 545nm with a spectrophotometer, repeat the experiment 3 times, and calculate the degree of hemolysis according to the formula. The hemolysis rate is expressed as a percentage and is calculated as follows: hemolysis rate = (absorbance of test sample - absorbance of negative control) / (absorbance of positive control - absorbance of negative control) × 100%. If the hemolysis rate is less than 5%, it means that the material meets the hemolysis test requirements for medical materials.

[0285] The test results are shown in Table 13. The results show that the hemolysis rate of the polyimide fiber fabric prepared by Example 1 is less than 5%. It can be preliminarily considered that the polyimide fabric meets the requirements of the hemolysis test standard.

[0286] Table 13 Hemolysis test results

[0287]

[0288] Example 15: Blood compatibility test - dynamic coagulation test

[0289] Preparation of anticoagulated whole blood: Fresh rabbit blood was anticoagulated by adding 0.0263 g / mL sodium citrate solution at a volume ratio of 9:1 to obtain anticoagulated whole blood.

[0290] Determine the absorbance of anticoagulated whole blood: Take 0.25 mL of anticoagulated whole blood, add 50 mL of distilled water and collect the supernatant. Use a spectrophotometer to measure its absorbance at a wavelength of 540 nm as the whole blood absorbance control value.

[0291] 1cm 2The polyimide fabric was placed in a beaker and kept in a constant temperature water bath at 37°C for 5 minutes. Then, 0.25 mL of anticoagulated whole blood was injected into the fabric with a syringe. After 10 minutes of constant temperature, 0.2 mL of 0.02 mol / L calcium chloride solution was injected. After mixing evenly, the temperature was kept constant for another 5 minutes. The beaker was taken out and 50 mL of normal saline was added. After mixing evenly for 10 minutes, the supernatant was taken out and its absorbance at 540 nm was measured by a spectrophotometer. The experiment was repeated 5 times. The coagulation index of the material was calculated according to the formula.

[0292] The test results are shown in Table 14 below. The results show that the coagulation index of the polyimide fiber fabric prepared in Example 1 is 80.8%, which is beneficial to blood coagulation.

[0293] Table 14 Coagulation test results

[0294]

[0295] Coagulation index = (1-Is / Iw) × 100%

[0296] Is: relative absorbance of blood after the mixture of blood and calcium chloride has been in contact with the sample for a set time;

[0297] Iw: Relative absorbance after blood is mixed with a certain amount of distilled water.

[0298] Example 16: Blood Compatibility Test-Platelet Adhesion

[0299] The ACD whole blood was separated at a speed of 1500 r / min for 10 min, and the upper platelet-rich plasma was taken and counted. The platelet-rich plasma was diluted with saline, and the volume ratio of platelet-rich plasma to saline was 1:4.5. Then, 1 cm 2 The polyimide fabric was placed in a platelet-rich plasma solution diluted with physiological saline at 37°C for 1 hour. After the sample was taken out, it was rinsed with physiological saline three times and counted. According to the formula, platelet adhesion rate = (platelet number before contact - platelet number after contact) / platelet number before contact.

[0300] The test results are shown in Table 15, which show that the platelet adhesion rate of the fabric made of polyimide fiber prepared in Example 1 is 0.92%, showing an extremely low adhesion rate.

[0301] Table 15 Platelet Adhesion Test Results

[0302]

[0303] Example 17: Animal skin allergy test

[0304] Hair removal: Four groups of rabbits were randomly divided into four groups, each group had 4 rabbits, half of them were male and half were female, and the other two groups were blank control group ( Figure 4 ), polyimide fabric experimental group ( Figure 5 ), positive control group (1% 2,4-dinitrochlorobenzene) ( Figure 6 ), negative control cotton cloth group ( Figure 7 ). 24 hours before the test, the hair on both sides of the spine of the animal's back was removed (about 6cm×6cm) to serve as the test and observation site.

[0305] Applying: Before applying, drop 0.2 mL of the positive control solution onto a 2.5 cm × 2.5 cm band-aid for later use. Directly contact the hair loss areas on both sides of the rabbit spine with a 1.2 cm × 1.2 cm cotton cloth or a fabric made of polyimide fiber prepared in Example 1 or a band-aid dripped with 1% 2,4-dinitrochlorobenzene, the positive control solution, and then fix the band-aid with a band-aid for 24 hours. After the contact period, remove the patch and remove the residue. Repeat the sensitization contact once in the same way on the 7th and 14th days. Observe the average value and sensitization rate of each animal at 1h, 24h, and 72h after the last contact.

[0306] Observation results: Observe the application site and surrounding skin tissue reactions at (1±0.1)h, (24±2)h and (72±2)h after removing the patch, including recording erythema, edema and necrosis. According to the occurrence of erythema and edema, it can be scored into 0, 1, 2, 3, 4 standard scoring levels. See the table below for details:

[0307] Table 16 Skin irritation scoring system

[0308]

[0309]

[0310] Result evaluation: Only the observation data of (24±2)h and (72±2)h were used for calculation. The erythema and edema irritation scores of each animal at each specified time were added up and then divided by the total number of observations 4 (2 test points × 2 observation times) to obtain the primary irritation score of each animal.

[0311] The average of the primary irritation scores of the four test animals is the primary irritation index. The skin irritation intensity is evaluated according to non-irritation (0-0.49), mild irritation (0.5-2.99), moderate irritation (3-5.00), and strong irritation (6-8). See Table 17 for details:

[0312] Table 17 Rabbit primary or cumulative irritation index type

[0313] Average score Reaction Type 0 none 0.1~0.49 Very slight 0.5~2.99 Mild 3~5 Moderate 6~8 Severe

[0314] The skin sensitization scoring standard is evaluated according to the incidence of sensitization, including no sensitization (0-10%), mild sensitization (11-30%), moderate sensitization (31-60%), high sensitization (61-80%), and extreme sensitization (81-100%).

[0315] During the experiment, no abnormal symptoms or death occurred in the animals. According to observations, the skin reaction on one side of the test group did not exceed that on one side of the blank control group, and the primary irritation index was 0. Under the experimental conditions of the embodiment, the type of allergic reaction of the polyimide fabric on rabbit skin was non-sensitizing.

[0316] Example 18: Animal Intact Skin Irritation Test

[0317] like Figure 8 and 9 The female and male rabbits after depilation were stimulated with irritants for 24 hours and multiple times, and the sensitization of the rabbit epidermis after depilation was observed.

[0318] Hair removal: 24 hours before the test, the hair on both sides of the spine of the animal's back was removed (about 10cm×15cm) to serve as the test and observation site.

[0319] Applying: Before applying, drop 0.2 mL of the positive control solution onto a 2.5 cm × 2.5 cm band-aid for later use. Directly contact the skin on both sides of the rabbit spine with a 1.2 cm × 1.2 cm cotton and the fabric made of polyimide fiber prepared in Example 1, and then fix the band-aid with a band-aid for 24 hours. After the contact period, remove the patch and remove the residue. Repeat the above steps every 24 hours for multiple stimulations.

[0320] Observation results: Observe the application site and surrounding skin tissue reactions at (1±0.1)h, (24±2)h and (72±2)h after removing the patch, including erythema, edema and necrosis, etc. The occurrence of erythema and edema can be scored into 0, 1, 2, 3, 4 standard scoring levels.

[0321] Result evaluation: Only the observation data of (24±2)h and (72±2)h were used for calculation. The erythema and edema irritation scores of each animal at each specified time were added up and then divided by the total number of observations 6 (2 test points × 3 observation times) to obtain the primary irritation score of each animal.

[0322] The average of the primary irritation scores of the four test animals is the primary irritation index. Calculate the primary irritation score of the control and subtract it from the primary irritation score of the test sample to obtain the primary irritation score. This value is the primary irritation index of the test sample.

[0323] During the experiment, no abnormal symptoms or death occurred in the animals. It was observed that the skin reaction on one side of the test group did not exceed that on the other side of the blank control group, and the primary irritation index was 0. Under the experimental conditions of the embodiment, under the conditions of stimulation for 24 hours and multiple stimulations, the reaction type of the polyimide fabric on the rabbit skin was no irritation.

[0324] Example 19: Animal skin irritation test

[0325] like Fig.10 , the female and male rabbits after depilation and injury were stimulated with irritants for 24 hours, and the sensitization of the rabbit epidermis after depilation was observed.

[0326] Hair removal: 24 hours before the test, the hair on both sides of the spine of the animal's back was removed (about 10cm×15cm) to serve as the test and observation site.

[0327] Broken skin: Use 75% alcohol to clean and disinfect the exposed skin. After the alcohol evaporates, use a sterilized blade to make a "+" shaped wound in the skin area.

[0328] Applying: Before applying, drop 0.2 mL of the positive control solution onto a 2.5 cm × 2.5 cm band-aid for later use. Directly contact the skin on both sides of the rabbit spine with a 2.5 cm × 2.5 cm cotton and the fabric made of polyimide fiber prepared in Example 1, and then fix and apply with a band-aid for at least 4 hours. After the contact period, remove the patch and remove the residue.

[0329] Observation results: Observe the application site and surrounding skin tissue reactions at (1±0.1)h, (24±2)h and (72±2)h after removing the patch, including erythema, edema and necrosis, etc. The occurrence of erythema and edema can be scored into 0, 1, 2, 3, 4 standard scoring levels.

[0330] Result evaluation: Only the observation data of (24±2)h and (72±2)h were used for calculation. The erythema and edema irritation scores of each animal at each specified time were added up and then divided by the total number of observations 6 (2 test points × 3 observation times) to obtain the primary irritation score of each animal.

[0331] The average of the primary irritation scores of the four test animals is the primary irritation index. Calculate the primary irritation score of the control and subtract it from the primary irritation score of the test sample to obtain the primary irritation score. This value is the primary irritation index of the test sample.

[0332] During the experiment, no abnormal symptoms or death occurred in the animals. According to observations, the skin reaction on one side of the polyimide group did not exceed that on the other side of the blank control group, so the primary irritation index was 0. Under the experimental conditions of the embodiment, the reaction type of the polyimide fabric on the injured rabbit skin was non-irritating.

[0333] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.

Claims

1. A polyimide fiber with intrinsic broad-spectrum antibacterial and antiviral properties, characterized in that: The polyimide fiber has a skin-core structure, the skin-core structure is formed by wet spinning of a polyamic acid spinning solution, and the polyimide fiber has a rough outer surface derived from wet spinning, wherein the roughness Ra of the rough outer surface is 0.1-0.4 μm; Furthermore, the polyimide fiber has antibacterial and antiviral activities in itself without any additional antibacterial and antiviral agents. Wherein, the antibacterial activity includes antibacterial activity against the following bacteria or fungi: Escherichia coli, Candida albicans and Staphylococcus aureus; The antiviral activity includes antiviral activity against the following viruses: vesicular stomatitis virus (VSV), novel coronavirus pseudovirus and influenza virus; Wherein, the polyimide fiber is prepared by a method comprising the following steps: (S1) providing a polyamic acid spinning solution, wherein the polyamic acid spinning solution comprises: a first solvent, a diamine compound and a dianhydride compound, wherein the diamine compound and the dianhydride compound form polyamic acid through a polymerization reaction in the first solvent; the concentration of the polyamic acid spinning solution is 5 to 20 wt%; (S2) extruding the polyamic acid spinning solution through a spinneret and coagulating it in a coagulation bath to form polyamic acid fibers, wherein the coagulation bath is pure water, and the temperature of the pure water is 40 to 60° C.; the depth of the coagulation bath well is 40 to 60 cm; (S3) subjecting the polyamic acid fiber to thermal imidization treatment to form the polyimide fiber; Wherein, the thermal imidization treatment includes thermal stretching; Wherein, the diamine compound is selected from the following group: p-phenylenediamine, diaminodiphenyl ether, diaminodiphenylmethane, diaminobenzophenone, or a combination thereof; The dianhydride compound is selected from the group consisting of pyromellitic dianhydride, biphenyltetracarboxylic dianhydride, biphenyl ether dianhydride, benzophenone tetracarboxylic dianhydride, or a combination thereof; and The first solvent is selected from the group consisting of N,N-dimethylformamide, N-methylpyrrolidone, N,N-dimethylacetamide, or a combination thereof; The molar ratio of the diamine compound to the dianhydride compound is (0.95-1.05):(0.95-1.05); The cross section of the polyimide fiber is a uniformly circular shape.

2. The polyimide fiber according to claim 1, characterized in that The polyimide fiber has one or more of the following properties: (a) Fineness 0.8~7 dtex; (b) breaking strength>4.0 cN / dtex; (c) Elongation at break > 5.0%; (d) Moisture regain under the test conditions of 20℃×65% is 0.5% to 2%; (e) Dry heat shrinkage under the test conditions of 280℃×30min is less than 0.6%; (f) Limiting oxygen index ≥ 36%; (g) Long-term use temperature ≤ 280℃.

3. The polyimide fiber according to claim 1, characterized in that The temperature of the thermal imidization treatment is ≤400°C.

4. A method for preparing the polyimide fiber according to claim 1, characterized in that: The steps include: (S1) providing a polyamic acid spinning solution, wherein the polyamic acid spinning solution comprises: a first solvent, a diamine compound and a dianhydride compound, wherein the diamine compound and the dianhydride compound form polyamic acid through a polymerization reaction in the first solvent; (S2) extruding the polyamic acid spinning solution through a spinneret and coagulating it in a coagulation bath to form polyamic acid fibers, wherein the coagulation bath is pure water; (S3) The polyamic acid fiber is subjected to a thermal imidization treatment to form the polyimide fiber according to claim 1.

5. A fabric, characterized in that: The fabric contains the polyimide fiber according to claim 1.

6. Use of the polyimide fiber according to claim 1 or the fabric according to claim 5, characterized in that: Used to prepare antimicrobial products.

7. A method for inhibiting pathogens in vitro, characterized in that: The method comprises the steps of: contacting the polyimide fiber or fabric thereof according to claim 1 with pathogens, thereby inhibiting the pathogens.